De Pascale, Gennaro
 Distribuzione geografica
Continente #
NA - Nord America 7.968
EU - Europa 5.753
AS - Asia 5.005
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 147
OC - Oceania 26
AN - Antartide 1
Totale 20.116
Nazione #
US - Stati Uniti d'America 7.734
SG - Singapore 2.184
IT - Italia 1.410
DE - Germania 1.337
CN - Cina 1.215
SE - Svezia 773
BR - Brasile 755
FR - Francia 433
VN - Vietnam 418
PL - Polonia 310
GB - Regno Unito 281
UA - Ucraina 253
IE - Irlanda 245
HK - Hong Kong 175
IN - India 167
FI - Finlandia 165
ID - Indonesia 138
JP - Giappone 135
BD - Bangladesh 129
TR - Turchia 129
RU - Federazione Russa 115
NL - Olanda 112
CA - Canada 108
AR - Argentina 83
MX - Messico 67
ES - Italia 60
AT - Austria 49
KR - Corea 47
IQ - Iraq 42
ZA - Sudafrica 41
BE - Belgio 35
PK - Pakistan 35
CO - Colombia 32
IR - Iran 27
CH - Svizzera 26
VE - Venezuela 24
SA - Arabia Saudita 23
AU - Australia 22
CZ - Repubblica Ceca 21
EC - Ecuador 19
EG - Egitto 18
JM - Giamaica 17
LT - Lituania 17
PH - Filippine 17
CL - Cile 15
MA - Marocco 15
JO - Giordania 14
GR - Grecia 13
IL - Israele 13
UZ - Uzbekistan 13
PE - Perù 12
PT - Portogallo 12
DZ - Algeria 11
KE - Kenya 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
ET - Etiopia 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
RO - Romania 9
RS - Serbia 9
UY - Uruguay 9
PY - Paraguay 8
EE - Estonia 7
MD - Moldavia 7
MK - Macedonia 7
NI - Nicaragua 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
VA - Santa Sede (Città del Vaticano) 7
EU - Europa 6
MY - Malesia 6
NP - Nepal 6
AZ - Azerbaigian 5
BO - Bolivia 5
GE - Georgia 5
HR - Croazia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
LB - Libano 4
OM - Oman 4
PS - Palestinian Territory 4
SN - Senegal 4
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
Totale 19.828
Città #
Singapore 1.204
San Jose 835
Ashburn 810
Chandler 725
Rome 265
Warsaw 254
Dublin 241
New York 236
Beijing 228
Milan 190
Los Angeles 184
The Dalles 181
Jacksonville 164
Hong Kong 155
Ho Chi Minh City 147
Ann Arbor 143
San Mateo 133
Chicago 132
Nanjing 130
Hefei 126
Tokyo 121
Jakarta 117
Lauterbourg 115
Munich 110
Hanoi 99
Houston 93
Wilmington 93
Dallas 92
Dearborn 87
Fairfield 85
Frankfurt am Main 84
Nürnberg 84
Boston 83
Seattle 82
Woodbridge 82
São Paulo 76
Council Bluffs 69
Buffalo 67
Helsinki 67
Marseille 65
Izmir 64
Cattolica 61
Moscow 57
Redwood City 53
London 51
Nanchang 50
North Bergen 50
Princeton 47
Boardman 46
Santa Clara 46
Nuremberg 44
Lawrence 43
Seoul 41
Atlanta 39
Brooklyn 37
Hangzhou 36
Phoenix 36
Denver 35
Orem 35
St Louis 34
Stockholm 33
Kent 32
Bremen 31
Tianjin 31
Chennai 30
Kraków 30
Kunming 30
Brussels 29
Cambridge 28
Montreal 26
Paris 26
Mexico City 25
Belo Horizonte 24
Tukwila 24
Turku 24
Augusta 23
Johannesburg 23
Lappeenranta 23
Redmond 23
Guangzhou 22
Lancaster 22
Norwalk 22
Toronto 22
Poplar 21
Pune 21
Padova 20
Shanghai 20
Amsterdam 19
Brasília 19
Da Nang 19
Rio de Janeiro 19
Vienna 19
Bologna 18
Hebei 18
Manchester 18
Mountain View 18
Dhaka 17
Kocaeli 17
Washington 17
Ankara 16
Totale 10.078
Nome #
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 396
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 364
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 359
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 348
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 342
Noninvasive ventilation for the immunocompromised patient: always appropriate? 333
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 315
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 309
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 286
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 281
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 268
Colistin use in critically ill patients: in search of the optimal dosing. 263
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 256
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 237
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 232
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 215
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 212
Data on the application of early coagulation support protocol in the management of major trauma patients 204
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 202
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 198
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 196
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 196
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 194
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 193
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 193
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 192
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 192
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 191
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 184
High vs Low PEEP in Patients With ARDS Exhibiting Intense Inspiratory Effort During Assisted Ventilation: A Randomized Crossover Trial 183
Neurological involvement during legionellosis, look beyond the lung 181
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 181
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 181
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 179
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 174
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 172
The importance of airway and lung microbiome in the critically ill 171
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 170
Sarilumab use in severe SARS-CoV-2 pneumonia 170
Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality 167
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 167
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 165
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 163
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 161
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 160
Physiological effects of awake prone position in acute hypoxemic respiratory failure 158
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 158
Neurological involvement during Legionellosis, look beyond the lung 157
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 157
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 156
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 156
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis 153
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 153
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 149
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 147
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 141
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 140
Lice, rodents, and many hopes: a rare disease in a young refugee 140
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 138
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 135
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 135
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 133
The place of dexmedetomidine light sedation in patients with acute brain injury 132
Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis 130
Recruitment-to-inflation ratio for bedside PEEP selection in acute respiratory distress syndrome 130
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 130
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 129
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy 128
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 128
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 127
Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study 124
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 124
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 124
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 124
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 124
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 122
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 121
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 121
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 119
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 119
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 118
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 117
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 117
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 116
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 116
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 116
Aerosolized colistin cost-effectiveness. Response 116
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 115
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 115
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 114
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 113
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 113
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 111
Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy 110
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 108
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 108
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 107
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 107
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 106
Totale 17.140
Categoria #
all - tutte 77.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.030 0 75 67 70 86 59 24 168 60 72 167 182
2022/20232.181 236 271 139 300 146 240 107 204 252 110 112 64
2023/20241.383 80 288 64 60 69 201 101 97 42 79 146 156
2024/20252.842 81 70 206 131 187 118 180 138 443 280 538 470
2025/20267.597 963 239 421 829 1.269 409 1.289 394 579 525 389 291
2026/20271.353 314 1.039 0 0 0 0 0 0 0 0 0 0
Totale 20.116